Nucleoside Reverse Transcriptase Inhibitor Procedures

Project Title Nucleoside Reverse Transcriptase Inhibitor Procedures
Date Posted
Monday, January 7, 2013
Project ID
MSY3_STR85
Status
Complete
Deliverables
Description

Summary table assessment of the occurrence of procedure codes for selected nucleoside reverse transcriptase inhibitors, including Injection Zidovudine 10 MG (HCPCS Code J3485), Zidovudine Oral 100 MG (HCPCS Code S0204), and Didanosine 25 MG (HCPCS Code S0137). Results were generated using the Mini-Sentinel Distributed Query Tool and the Healthcare Common Procedure Coding System (HCPCS) Summary Table.Summary tables are precompiled stratified counts. Queries were run in the outpatient setting. Queries were executed in June-July 2012. This report includes data from 16 Data Partners.

If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to info@mini-sentinel.org.

The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.

Medical Product
didanosine
injection zidovudine
zidovudine oral
Time Period
2000 - 2011
Assessment Type
Exploratory Analyses
Study Type
Summary Table
Data Sources
Mini-Sentinel Distributed Database (MSDD)
FDA Center
CDER